https://www.newpharmaitaly.it/opti-medical-systems-ottiene-il-marchio-ce-per-il-suo-kit-di-analisi-opti-sars-cov-2-rna-pcr-per-il-rilevamento-del-virus-che-causa-il-covid-19/ Il portale delle news in ambito farmaceutico Fri, 05 Jun 2020 09:01:16 +0000 hourly 1 https://wordpress.org/?v=6.9.4